Long-Term Transcriptomic Reprogramming in Peripheral Blood Mononuclear Cells of Severe COVID-19 Survivors Reveals Pro-Oncogenic Signatures and Cancer-Associated Hub Genes
| dc.contributor.author | Duru Cetinkaya, Pelin | |
| dc.contributor.author | Kayalar, Ozgecan | |
| dc.contributor.author | Eldem, Vahap | |
| dc.contributor.author | Argun Baris, Serap | |
| dc.contributor.author | Kokturk, Nurdan | |
| dc.contributor.author | Kuralay, Selim Can | |
| dc.contributor.author | Bayram, Hasan | |
| dc.date.accessioned | 2026-07-01T11:39:17Z | |
| dc.date.available | 2026-07-01T11:39:17Z | |
| dc.date.issued | 2025 | |
| dc.department | Düzce Üniversitesi | |
| dc.description.abstract | This study examined the long-term transcriptomic reprogramming in peripheral blood mononuclear cells (PBMCs) of severe COVID-19 patients and its effects for cancer development. RNA sequencing was conducted on PBMCs obtained from healthy controls, COVID-19 patients without pneumonia, and COVID-19 patients exhibiting severe pneumonia one year post-infection. Differential gene expression analysis identified a sustained pro-oncogenic molecular signature, especially among severe COVID-19 patients. Functional enrichment analysis revealed a substantial enrichment of cancer-associated pathways, encompassing apoptosis, viral carcinogenesis, and transcriptional dysregulation. Notably, the autophagy-related gene SQSTM1/P62 was recognized as a distinctive hub gene within the severe COVID-19 patients, interacting with pivotal genes associated with inflammation, apoptosis, and cancer advancement. Survival analysis demonstrated that elevated expression of COVID-19-associated hub genes correlated with unfavorable prognosis in various cancer types, including adrenocortical carcinoma, bladder urothelial carcinoma, and brain lower-grade glioma. These findings indicate that severe COVID-19 infection may establish a systemic milieu favorable to cancer development or recurrence, highlighting the necessity of prolonged oncological monitoring in these patients. Finding specific molecular targets and pathways can help us understand how COVID-19 might be linked to a higher risk of cancer. | |
| dc.description.sponsorship | Research Support Fund of the Turkish Thoracic Society [Y-2022-196] -- This research was funded by the Research Support Fund of the Turkish Thoracic Society (TTD). Grant number: Y-2022-196. | |
| dc.identifier.doi | 10.3390/v17121608 | |
| dc.identifier.issn | 1999-4915 | |
| dc.identifier.issue | 12 | |
| dc.identifier.orcid | 0000-0001-7320-976X | |
| dc.identifier.orcid | 0000-0003-4618-168X | |
| dc.identifier.orcid | 0000-0001-8610-2937 | |
| dc.identifier.orcid | 0000-0002-4429-9441 | |
| dc.identifier.orcid | 0000-0001-7706-9311 | |
| dc.identifier.orcid | 0000-0001-9107-2381 | |
| dc.identifier.orcid | 0000-0002-9047-7608 | |
| dc.identifier.pmid | 41472277 | |
| dc.identifier.scopus | 2-s2.0-105026427445 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.uri | https://doi.org/10.3390/v17121608 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12684/23212 | |
| dc.identifier.volume | 17 | |
| dc.identifier.wos | WOS:001647424900001 | |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Mdpi | |
| dc.relation.ispartof | Viruses-Basel | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WOS_20260623 | |
| dc.subject | Covid-19 | |
| dc.subject | Transcriptomics | |
| dc.subject | Pbmcs | |
| dc.subject | Long-Term Effects | |
| dc.subject | Cancer Risk | |
| dc.subject | Differentially Expressed Genes | |
| dc.subject | Bioinformatics Analysis | |
| dc.title | Long-Term Transcriptomic Reprogramming in Peripheral Blood Mononuclear Cells of Severe COVID-19 Survivors Reveals Pro-Oncogenic Signatures and Cancer-Associated Hub Genes | |
| dc.type | Article |












